Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients

被引：31
|
作者：
Legrand, Matthieu [1 ,2 ,3 ,4 ]
Michel, Thibault [1 ,2 ]
Daudon, Michel [5 ,6 ]
Benyamina, Mourad [1 ,2 ]
Ferry, Axelle [1 ,2 ]
Soussi, Sabri [1 ,2 ]
Maurel, Veronique [1 ,2 ]
Chaussard, Maite [1 ,2 ]
Chaouat, Marc [3 ,7 ]
Mimoun, Maurice [3 ,7 ]
Verine, Jerome [3 ,8 ]
Mallet, Vincent [9 ]
Mebazaa, Alexandre [1 ,2 ,3 ,4 ]
机构：
[1] Hop St Louis, AP HP, Dept Anaesthesiol & Crit Care, F-75010 Paris, France
[2] Hop St Louis, AP HP, Burn Unit, F-75010 Paris, France
[3] Univ Paris Diderot, Paris, France
[4] INSERM, U942, F-75475 Paris, France
[5] Hop Tenon, AP HP, Lab Lithiases, Serv Explorat Fonct Multidisciplinaires, F-75020 Paris, France
[6] UPMC, Univ Sorbonne, INSERM, UMR S 1155, F-75020 Paris, France
[7] Hop St Louis, AP HP, Plast Surg, F-75010 Paris, France
[8] Hop St Louis, AP HP, Dept Pathol, F-75010 Paris, France
[9] Univ Paris 05, Grp Hosp Cochin Port Royal, AP HP, Inst Pasteur,Serv Hepatol,Unite Mixte Serv 020, Paris, France
来源：
INTENSIVE CARE MEDICINE | 2016年 / 42卷 / 06期
关键词：
SMOKE-INHALATION;
D O I：
10.1007/s00134-016-4252-4
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1080 / 1081
页数：2
相关论文
共 50 条
  • [31] Levetiracetam use in critically ill patients
    Szaflarski, Jerzy P.
    Meckler, Jason M.
    Szaflarski, Magdalena
    Shutter, Lori A.
    Privitera, Michael D.
    Yates, Stephen L.
    NEUROCRITICAL CARE, 2007, 7 (02) : 140 - 147
  • [32] Nephropathy in critically ill patients without preexisting renal disease
    Polena, S
    Yang, S
    Alam, R
    Gricius, J
    Gupta, JR
    Badalova, N
    Chuang, P
    Gintautas, J
    Conetta, R
    Proceedings of the Western Pharmacology Society, Vol 48, 2005, 48 : 134 - 135
  • [33] Contrast-Induced Nephropathy in Aged Critically Ill Patients
    Palli, Eleni
    Makris, Demosthenes
    Papanikolaou, John
    Garoufalis, Grigorios
    Zakynthinos, Epaminondas
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2014, 2014
  • [34] Acute kidney injury in critically ill burn patients. Risk factors, progression and impact on mortality
    Palmieri, Tina
    Lavrentieva, Athina
    Greenhalgh, David G.
    BURNS, 2010, 36 (02) : 205 - 211
  • [35] Characteristics of bloodstream infection and initial antibiotic use in critically ill burn patients and their impact on patient prognosis
    Zhang Yin
    Wu Beiwen
    Ma Zhenzhu
    Chen Erzhen
    Zhang Qin
    Dou Yi
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [36] Characteristics of bloodstream infection and initial antibiotic use in critically ill burn patients and their impact on patient prognosis
    Zhang Yin
    Wu Beiwen
    Ma Zhenzhu
    Chen Erzhen
    Zhang Qin
    Dou Yi
    Scientific Reports, 12
  • [37] EFFECTS OF PROPHYLACTIC USE OF HALOPERIDOL IN CRITICALLY ILL PATIENTS WITH A HIGH RISK FOR DELIRIUM
    van den Boouatirdi, M.
    Schoonhoven, L.
    van Achterberi, T.
    van der Hoeven, J. G.
    Pickkers, P.
    INTENSIVE CARE MEDICINE, 2011, 37 : S201 - S201
  • [38] Ten tips for managing critically ill burn patients: follow the RASTAFARI!
    Legrand, Matthieu
    Guttormsen, Anne Berit
    Berger, Mette M.
    INTENSIVE CARE MEDICINE, 2015, 41 (06) : 1107 - 1109
  • [39] Re: Enteral Nutrition Intolerance in Critically Ill Septic Burn Patients
    Dissanaike, Sharmila
    Kesey, Jenna
    JOURNAL OF BURN CARE & RESEARCH, 2016, 37 (05): : E499 - E499
  • [40] PHARMACOKINETICS OF MICAFUNGIN IN PLASMA AND BURN ESCHARES IN CRITICALLY ILL BURNED PATIENTS
    Jose Asensio, Maria
    Sanchez, Manuel
    Galvan, Beatriz
    Herrero, Eva
    Cachafeiro, Lucia
    Agrifolio, Alexander
    Luque, Sonia
    Garcia-de-Lorenzo, Abelardo
    CRITICAL CARE MEDICINE, 2014, 42 (12)
12345